I'm excited about this, and I hope that it won't be a month or so before the summary is posted (I suppose they would have told if it wasn't due in a few days or so?). The recording would be nice to see soon too of course, but at least some info on the main points. What rumours (and KDM's hints) says, as far as I've understood, is that there is a specific auto-immune factor that now is identified, which is the reason why Rituximab has it's effect - the auto-immunity is temporarily switched off by depleting the b-cells, but returns when the cells are regenerated. Chronic infection with pathogens like bartonella and borrelia is a key factor to why the auto-immunity develops. And according to KDM's model of the disease immunological dysfunctions are key factors to why ME patients are prone to chronic infections. I don't know if there might be any specific treatment options for the auto-immune reaction, but restoring normal function in the immune system in a broad sense is probably important, which is exactly the core of KDM's treatments since many years. The latest PCR tests are more sensitive and KDM now identifies a lot of bartonella and borrelia infections among his patients, which he believes needs to be treated with long term antibiotics too since they do a lot of stuff that disrupts the immune system, but he seems to believe that you definitely have to treat the immune system deficits too to be able to get rid of the infection (something he's trying to put forward in the ILADS). But maybe the presentation's got some other information that I'm not aware of, hoping to hear about it soon!